Qyuns Therapeutics Co., Ltd. Class H (HK:2509) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Qyuns Therapeutics Co., Ltd. announced the resignation of Dr. Xue Mingyu as a non-executive director due to personal commitments. Despite stepping down, Dr. Xue will continue contributing as a consultant. The company plans to elect a new director and committee member promptly to maintain strategic operations.
For further insights into HK:2509 stock, check out TipRanks’ Stock Analysis page.